[The effects of LH-RH agonist alone or with flutamide in the treatment of stage D2 prostate cancer].

Abstract

We compared the clinical efficacy of treatment with a luteinizing hormone-releasing hormone (LH-RH) agonist alone to combined androgen blockade (CAB) with a LH-RH agonist and fiutamide. A total of 66 stage D2 prostate cancer patients were enrolled from Nov. 1992 to Mar. 1996 (n = 30: LH-RH agonist alone, n = 36 CAB). Serum PSA levels after 3 months of… (More)

Topics

Cite this paper

@article{Ito1998TheEO, title={[The effects of LH-RH agonist alone or with flutamide in the treatment of stage D2 prostate cancer].}, author={Takaaki Ito and T Aizawa and Satoshi Yamamoto and Yoshitaka Ohkubo and Seiichi Tsujino and Masaru Miki}, journal={Hinyokika kiyo. Acta urologica Japonica}, year={1998}, volume={44 7}, pages={477-80} }